CUSIP No. G85347105 | SCHEDULE13G | Page 1 3 of 13 Pages |
EXHIBIT 1
AGREEMENT AS TO JOINT FILING OF SCHEDULE 13G
The undersigned hereby agree that the Schedule 13G relating to the common stock of Strongbridge Biopharma plc, and any further amendments thereto, to which this Agreement as to Joint Filing of Schedule 13G is attached as an exhibit is filed on behalf of each of them pursuant to and in accordance with the provisions of Rule13d-1(k) under the Securities Exchange Act of 1934, as amended.
Nathaniel D. Hukill | ||
/s/ Nathan D. Hukill | ||
Name: | Nathan D. Hukill | |
Title: | Authorized Signatory | |
CR Group L.P. | ||
CRG Partners III L.P. | ||
CRG Partners III – Parallel Fund “A” L.P. | ||
CRG Partners III – Parallel Fund “B” (Cayman) L.P. | ||
CRG Partners III (Cayman) Lev AIV I L.P. | ||
CRG Partners III (Cayman) Unlev AIV I L.P. | ||
By: | /s/ Andrei Dorenbaum | |
Name: | Andrei Dorenbaum | |
Title: | Co-Founder and President | |
CRG Issuer2017-1 | ||
By: | /s/ Andrei Dorenbaum | |
Name: | Andrei Dorenbaum | |
Title: | Authorized Signatory |